CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 10,964 shares at $9.81 ($107,575)
- 144 Insider Sale of Securities
- 4 Planned sale SVP, Chief Accounting Officer sold 1,562 shares at $9.15 ($14,291)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 4 Planned sale Director sold 10,960 shares at $12.52 ($137,219)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale EVP and General Counsel sold 76 shares at $8.22 ($625)
- 144 Insider Sale of Securities
- 4 Grant or award EVP & Chief Financial Officer acquired 75,000 shares (grant or award)
- 4 Planned sale EVP and General Counsel sold 4,397 shares at $10.11 ($44,454)
- 144 Insider Sale of Securities
- 4 Planned sale EVP and General Counsel sold 3,750 shares at an average $8.62 ($32,332)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
Page 10 of 41 · 806 filings